Notably, the unique role of PPARa as a transcriptional hub for metabolic regulation provides mechanistic justification for its ferroptosis-modulating capacity [22, 23]
Combining baclofen and gabapentin with alcohol or other central nervous system depressants can increase sedation and respiratory risks
Current research has not demonstrated a direct effect on: However, because peptide therapy research continues to evolve, patients should avoid assuming that the absence of evidence automatically guarantees long-term safety
Matsuoka M, Igisu H, Kohriyama K, et al
10.3389/fendo.2025.1520362 103 ZhengX.LinD.ZhangY.LinY.SongJ.LiS.et al (2017)
According to the public registry, the trial was completed, and the results suggest a favorable safety profile with no significant adverse events reported (ClinicalTrials.gov Identifier: NCT03416053)